论文部分内容阅读
《中国药典》自1963年版开始收载金银花,规定供药用的金银花植物来源只有一种,即忍冬科植物忍冬的干燥花蕾。1977年版《中国药典》在金银花标准中增收了其他3个植物来源,分别是山银花(华南忍冬)、红腺忍冬和毛花柱忍冬。经查,当年药典工作属恢复初期,新增的3个来源未能找到支持其收载入药典的相关研究资料。鉴于实践中金银花和山银花药材在药用历史、来源、性状、化学成分等方面的差异,经过专业委员会审定,2005版
“Chinese Pharmacopoeia” since the 1963 edition contains honeysuckle, provided for medicinal honeysuckle plants only one source, namely honeysuckle dry honeysuckle flower buds. The 1977 edition of the Chinese Pharmacopoeia added three other plant sources to the honeysuckle standard, namely, honeysuckle (honeysuckle), honeysuckle and honeysuckle. After investigation, when the work of pharmacopoeia is an early recovery, the three new sources failed to find relevant data to support their inclusion in the Pharmacopoeia. In view of the practice of honeysuckle and medicinal herbs in the mountains of medicinal history, sources, traits, chemical composition differences, after the approval of the Professional Committee, 2005 edition